(269 days)
No
The description focuses on data collection, transmission, and communication, with no mention of AI/ML algorithms for analysis or interpretation.
No
This device is a monitoring system, not a therapeutic one. It collects and transmits physiological data and provides communication, but it does not treat or cure any medical condition.
No
The device is described as a physiological monitoring system that collects and transmits vital signs and other physiological data. It does not state that it performs a diagnostic function, but rather provides data for a healthcare practitioner to review.
No
The device description explicitly states it is a "tabletop unit" and includes a "Patient Terminal" that connects via telephone line or Ethernet, indicating the presence of physical hardware components beyond just software.
Based on the provided information, the Viterion 100 TeleHealth Monitor is not an In Vitro Diagnostic (IVD) device.
Here's why:
- IVD Definition: In Vitro Diagnostics are devices intended for use in the collection, preparation, and examination of specimens taken from the human body (such as blood, urine, or tissue) to provide information for the diagnosis, monitoring, or treatment of disease.
- Viterion 100 Function: The Viterion 100 collects and transmits physiological data directly from the patient using connected or manually entered measurements (Blood Pressure, SpO2, Weight, Blood Glucose, Temperature, Peak Flow). It does not process or analyze specimens taken from the body.
- Intended Use: The intended use is for physiological monitoring and communication between a remote patient and healthcare practitioner. This aligns with telehealth and remote patient monitoring, not in vitro testing.
Therefore, the Viterion 100 TeleHealth Monitor falls under the category of physiological monitoring systems, not In Vitro Diagnostics.
N/A
Intended Use / Indications for Use
The Viterion100 TeleHealth Monitor is a physiological monitoring system. The system collects, accumulates, transmits patient vital signs and other physiological data from a patient who may be remote from the healthcare practitioner to the practitioner, and provides communication between the patient and practitioner. It can record physiological information such as:
- Blood Pressure/Pulse
- Blood Hemoglobin Oxygen Saturation (SpO2)
- Body Weight
- Blood Glucose
- Temperature
- Respiratory Peak Flow
Product codes
MWI
Device Description
The Viterion 100 TeleHealth Monitor is a physiological monitoring system. The system collects, accumulates, transmits patient vital signs and other physiological data from a patient who may be remote from the healthcare practitioner to the practitioner, and provides communication between the patient and practitioner.
The physiological monitoring instruments, selected by the healthcare practitioner, operate in conjunction with the Patient Terminal located in the patient's home, a hospital room, nursing home, or other healthcare facility. The Patient Terminal connects to the server via a conventional telephone line or through the Ethernet.
The Viterion 100 TeleHealth Monitor system is a software controlled physiological monitoring device for which the healthcare provider is remotely located from the patient. It is a tabletop unit that communicates with the healthcare provider via a server. The built-in interface allows monitoring of the data directly from the selected physiological instruments. It also allows manual entry of other physiological measurements for those instruments that do not directly connect to the system.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.2300 Cardiac monitor (including cardiotachometer and rate alarm).
(a)
Identification. A cardiac monitor (including cardiotachometer and rate alarm) is a device used to measure the heart rate from an analog signal produced by an electrocardiograph, vectorcardiograph, or blood pressure monitor. This device may sound an alarm when the heart rate falls outside preset upper and lower limits.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized symbol that resembles three overlapping human profiles or figures.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
NOV 1 7 2003
Viterion TeleHealthcare LLC c/o Ms. Thuy Nguyen Manager, Quality Assurance 555 White Plains Road Tarrytown, NY 10591
Re: K030419
Trade Name: Viterion 100 TeleHealth Monitor Regulation Number: 21 CFR 870.2300 Regulation Name: Cardiac monitor (including cardiotachometer and rate alarm) Regulatory Class: Class II (two) Product Code: MWI Dated: August 19, 2003 Received: August 22, 2003
Dear Ms. Nguyen:
This letter corrects our substantially equivalent letter of November 6, 2003, regarding the trade name and company name.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent [{for the indications for use stated in the enclosure)] to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Page 2 - Ms. Thuy Nguyen
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to continue marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4646. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at their toll free number (800) 638-2041 or at (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.
Sincerely yours,
fr
Meffermay
Bram D. Luckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Image /page/2/Picture/2 description: The image shows the number K030419 at the top. Below that is the word "Viterion" in large, bold letters. Underneath "Viterion" are the words "TeleHealthcare" in a smaller font. The last line says "A Bayer-Panasonic Company".
1. 510(k) Summary
For Public Disclosure
| Date Prepared: | February 7, 2003 |
|---|---|
| Submitter: | Viterion TeleHealthcare LLC |
| 555 White Plains Road | |
| Tarrytown, NY 10591 | |
| Phone: (914) 333-6600 | |
| Fax: (914) 333-6470 |
Sean M. Curry Contact Person: 16787 Bernardo Center Drive, Suite A-1 San Diego, CA 92128 Phone: (858) 675-8200 Fax: (858) 675-8201
Proprietary Name: Viterion 100 TeleHealth Monitor
Common Name: Physiological Monitoring System
Classification: Class II
Product Code: 74 MWI, 870.2300
Substantial Equivalence Claimed to:
-
- K004050 Panasonic Tele-Homecare System, Matsushita Electric Industrial Co., Ltd.
-
- K952979 HANC Network, HealthTech Services Corp
Description/Intended Use:
The Viterion 100 TeleHealth Monitor is a physiological monitoring system. The system collects, accumulates, transmits patient vital signs and other physiological data from a patient who may be remote from the healthcare practitioner to the practitioner, and provides communication between the patient and practitioner.
3
The physiological monitoring instruments, selected by the healthcare practitioner, operate in conjunction with the Patient Terminal located in the patient's home, a hospital room, nursing home, or other healthcare facility. The Patient Terminal connects to the server via a conventional telephone line or through the Ethernet.
Summary of Technological Characteristics:
The Viterion 100 TeleHealth Monitor system is a software controlled physiological monitoring device for which the healthcare provider is remotely located from the patient. It is a tabletop unit that communicates with the healthcare provider via a server. The built-in interface allows monitoring of the data directly from the selected physiological instruments. It also allows manual entry of other physiological measurements for those instruments that do not directly connect to the system.
4
3. Indications for Use Statement
510(k) Number: K030419 Device Name: Viterion 100 TeleHealth Monitor
Indications for Use:
The Viterion100 TeleHealth Monitor is a physiological monitoring system. The system collects, accumulates, transmits patient vital signs and other physiological data from a patient who may be remote from the healthcare practitioner to the practitioner, and provides communication between the patient and practitioner. It can record physiological information such as:
- Blood Pressure/Pulse ●
- Blood Hemoglobin Oxygen Saturation (SpO2) ●
- Body Weight ●
- Blood Glucose ●
- Temperature .
- Respiratory Peak Flow ●
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
| -Concurrence of CDRH, Office of Device Evaluation (ODE) | ||
|---|---|---|
| Clara May | ||
| (Division Sign-Off) | ||
| Division of Cardiovascular Devices | ||
| 510(k) Number | K031419 | |
| Prescription Use | ||
| (Per 21 CFR 801.109) | OR | Over-the-Counter Use |
Viterion TeleHealthcare LLC Viterion 100 TeleHealth Monitor